CSI Market
Sign In | Register

Sanara Medtech Inc (SMTI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SMTI Annual Cash Flow →
Reviewing cash flow figures over time highlights how Sanara Medtech Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-0.01
Depreciation & amortization1.21
Amortization of Other Assets1.28
Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.14
Inventories Decrease /-Increase-0.23
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation2.52
Income (Loss) from Equity Method Investments-0.90
Paid-in-Kind Interest0.00
Re Acquisition Of Distributorship-
Gain On Fair Market Value Of Derivative Liabilities-
Gain Loss On Debt Settlement-
Loss On Debt Settlement-
Prepayment Expense-
Impairment Of Intangible Assets Excluding Goodwill-
Non Cash Debt Related Costs-
Stock Issued As Payment Of Expenses-
Stock Issued For Debt Related Costs-
Gain Loss On Joint Venture-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Interest Receivable From Related Parties Current-
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-
Common Stock Issued For Loan Extensions-
Gain Loss On Fair Market Value Of Derivative Liabilities-
Series D Preferred Shares Issued For Services-
Stock Issued During Period Value Issued For Services-
Embedded Derivative Gain Loss On Embedded Derivative Net-
Interest Expense On Convertible Debt-
Increase Decrease In Prepaid Deferred Expense And Other Assets Related Parties0.34
Debt Instrument Increase Accrued Interest-
Income taxes0.00
Equity Method Investment, Realized Gain (Loss) on Disposal0.00
Increase (Decrease) in Accounts Receivable0.70
Increase (Decrease) in Accounts Payable-0.94
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.25
Other Working Capital0.00
Other Noncash Expense0.17
Other net0.00
Payments for (Proceeds from) Other Operating Activities-4.14
Discontinued operations0.02
Net Cash flow from Operating Activities-0.43
Investing Activities
Capital Expenditures-0.05
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Received In Reverse Acquisition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.05
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Payments of Distributions to Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.53
Other net-0.16
Proceeds From Notes Payable Related Parties-
Repayments Of Notes Payable Related Parties-
Proceeds From Stock Subscriptions Payable-
Proceeds From Stock Subscriptions Receivable-
Borrowings On Debt-
Borrowings On Convertible Debt Net Of Original Issue Discounts-
Payments On Convertible Debt-
Advance On Future Non Controlling Interest Distribution-
Common Stock Issued For Employee Stock Purchase Plan-
Interest Expense Debt0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.68
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.48
Total Cash Flow-1.16
4 historic quarters locked

Sign in to unlock the full Sanara Medtech Inc cash flow history.

Sign In Create Free Account

About Sanara Medtech Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-037176

Figures are derived from filed reports and may be restated. Historical data is subject to revision.